TyG-BMI

There are 169 papers on TyG-BMI in aging research: 2 trials and 161 observational studies in people, 6 reviews.

Biomarker

169 papers study it95 more mention it99 findings

31 new papers in 30 daysSee all 264 papers on TyG-BMI

At a glance

Human observational studies link higher TyG-BMI with frailty, cardiometabolic multimorbidity, and cardiovascular disease; sarcopenia and osteoporosis associations point both ways. Mortality associations also differ: higher TyG-BMI is linked with higher mortality in people at CKM stages 0–3, but lower mortality in postmenopausal women with young-onset type 2 diabetes.

99 findings in 82 papers from 2021 to 2026, 36 of them since April 2026

“as well as with every 100 unit increase in TyG-BMI (HR: 1.70, 95% CI: 1.63–1.76, P < 0.001, E value = 2.79)”
Association of triglyceride-glucose related indices with the incidence of venous thromboembolism: a nationwide prospective cohort study based on the UK BiobankBMC cardiovascular disorders2026doi:10.1186/s12872-026-05735-7
  • Human trial2
  • Humans161

Effects

6

Depressive symptoms

downin humans1

1 study
  1. TyG-BMI is linked with lower depressive symptoms in humans (coefficient: -0.147; 95% CI: -0.292, -0.002).

    “In contrast, TyG-BMI (-0.147; -0.292, -0.002) and TyG-WC (-0.163; -0.306, -0.021) exhibited a negative relationship with depressive symptoms.”

    Humansn = 5,822

    The mediating role of depressive symptoms in the relationship between obesity-related triglyceride-glucose index and cognitive status among middle-aged and elderly adults: a large cohort study

    Frontiers in psychiatry

More on Depressive symptoms

Cognitive function

upin humans1

1 study
  1. TyG-BMI is linked with better cognitive function in humans (coefficient: 0.206; 95% CI: 0.069, 0.343).

    “The TyG-BMI (coefficient: 0.206; 95% confidence interval [CI]: 0.069, 0.343), TyG-WC (0.268; 0.135, 0.402), and TyG-WHtR (0.150; 0.013, 0.286) were positively associated with cognitive status.”

    Humansn = 5,822

    The mediating role of depressive symptoms in the relationship between obesity-related triglyceride-glucose index and cognitive status among middle-aged and elderly adults: a large cohort study

    Frontiers in psychiatry

Hypertension

no changein humans1

1 study
  1. TyG-BMI was not clearly linked with hypertension in patients with type 2 diabetes and prediabetes.

    “whereas TyG-BMI did not.”

    Humansin patients with type 2 diabetes and prediabetes

    Triglyceride-glucose index as a biochemical predictor of hypertension in patients with type 2 diabetes and prediabetes: Evidence from the NHANES database

    Journal of medical biochemistry

More on Hypertension

Cerebral microbleeds

no changein humans1

1 study
  1. TyG-BMI was not clearly linked with cerebral microbleeds in humans.

    “The TyG-BMI was not significantly associated with enlarged perivascular spaces, lacunes, or cerebral microbleeds.”

    Humansbrainn = 1,268

    Hypertension Mediates the Association of Triglyceride-Glucose-Body Mass Index With Vascular Brain Injury in Older Adults: A Population-Based Magnetic Resonance Imaging Study

    Journal of the American Heart Association

Poor self-rated mental health

no changein humans1

1 study
  1. TyG-BMI was not clearly linked with poor self-rated mental health in humans (TyG-BMI above threshold 204.3).

    “Above the threshold, no significant association was observed.”

    HumansTyG-BMI above threshold 204.3n = 2,951

    L-shaped association of triglyceride glucose-body mass index and self-rated mental health among the middle-aged and older adults: a national cohort study in China

    Frontiers in public health

Mortality

mediatesin humans1

1 study
  1. TyG-BMI is linked with mortality in humans (hypertension) (33.1% of the relationship).

    “TyG-BMI, TyG-WC, and TyG-WHtR indices accounted for 33.1%, 34.3%, and 19.1% of the relationship between CDAI and mortality, respectively.”

    Humanshypertensionn = 5,276

    Mediating role of triglyceride glucose-related index in the associations of composite dietary antioxidant index with cardiovascular disease and mortality in older adults with hypertension: a national cohort study

    Frontiers in nutrition

Upstream

1

LCN2

mediatesin humans1

1 study
  1. LCN2 is linked with TyG-BMI in humans (exploratory mediation analysis of neutrophil-associated cardiometabolic risk) (25.8%).

    “Exploratory mediation analysis yielded an estimated mediated proportion of 25.8% ( P < 0.001).”

    Humansexploratory mediation analysis of neutrophil-associated cardiometabolic riskn = 502

    Neutrophils and lipocalin-2 in triglyceride-glucose body mass index-related cardiometabolic risk among patients with rheumatoid arthritis: a multicenter study

    Scientific reports

More on LCN2

Associations

56

Mortality

upin humans4downin humans2no changein humans1mixedin humans1HR 0.65–1.99

8 studies
  1. TyG-BMI is associated with mortality in humans (CKM stages 0–3; fully adjusted analysis) (HR 1.99, 95% CI 1.21–3.28).

    “After full adjustment, all seven indices were independently associated with ACM; TyG-BMI showed the strongest association (HR = 1.99, 95% CI: 1.21–3.28)”

    HumansCKM stages 0–3; fully adjusted analysisMedian follow-up of 10.25 yearsn = 12,947

    Associations of triglyceride-glucose-obesity composite indices with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3 and their potential incremental value beyond a PREVENT-variable-based model

    Cardiovascular diabetology

  2. TyG-BMI is associated with mortality in humans after PSM, Q4 versus Q1 (HR 0.94, P = 0.44).

    “while the Q4-versus-Q1 association remained null after PSM (HR = 0.94, P = 0.44)”

    Humansafter PSM, Q4 versus Q1

    Divergent mortality associations of TyG-BMI in middle-aged and older adults: Parallel analyses of Chinese and US populations

    Experimental gerontology

  3. TyG-BMI is linked with a lower risk of mortality in humans (postmenopausal female patients with young-onset type 2 diabetes (YM group)) (HR 0.980, 95% CI 0.965-0.997, P = 0.018; -2% per 1 SD increase).

    “triglyceride-glucose-body mass index (TyG-BMI) was an independent protective factor for the YM group (HR = 0.980, 95% CI = 0.965-0.997) (P = 0.018).”

    Humanspostmenopausal female patients with young-onset type 2 diabetes (YM group)10-year follow-upfemalesn = 387

    Analysis of mortality risk and influencing factors in female patients with young-onset type 2 diabetes

    Frontiers in endocrinology

  4. TyG-BMI is associated with mortality in humans (HSV-positive) (HR 1.22, 95% CI 1.11–1.33).

    “TyG-BMI (HR: 1.22, 95% CI: 1.11-1.33)”

    HumansHSV-positiveMedian follow-up of 143 monthsn = 8,465

    TyG Index and Obesity-Related Measures in Relation to All-Cause Mortality Among HSV-Positive Adults

    International journal of endocrinology

  5. TyG-BMI is associated with mortality in humans (diabetes mellitus) (p-overall<0.0001, p-nonlinear<0.05).

    “A U-shaped relationship was found between METS-IR, TyG-BMI, eGDR, and all-cause mortality (p-overall<0.0001, p-nonlinear<0.05).”

    Humansdiabetes mellitus

    The Association between New Insulin Resistance Indices and All-Cause Mortality in Elderly DM Patients

    ADA Scientific Sessions 2025 abstract

  6. TyG-BMI is associated with mortality in humans (elderly diabetes patients) (p-overall < 0.0001, p-nonlinear < 0.05).

    “A U-shaped relationship exists between METS-IR, TyG-BMI, eGDR, and all-cause mortality (p-overall < 0.0001, p-nonlinear < 0.05).”

    Humanselderly diabetes patientsn = 1,248

    The association between new insulin resistance indices and all-cause mortality in elderly patients with diabetes: a prospective cohort study

    Diabetology & metabolic syndrome

  7. TyG-BMI is associated with mortality in humans (diabetes mellitus) (HR = 0.65, 95% CI 0.43-0.96).

    “the 3rd quartile demonstrated a significant association with all-cause mortality (model 2: HR = 0.64, 95% CI 0.46-0.89, P = 0.009; model 3: HR = 0.65, 95% CI 0.43-0.96, P = 0.030)”

    Humansdiabetes mellitusmedian follow-up of 77.3 monthsn = 1,363

    The impact of triglyceride glucose-body mass index on all-cause and cardiovascular mortality in elderly patients with diabetes mellitus: evidence from NHANES 2007-2016

    BMC geriatrics

  8. TyG-BMI is associated with mortality in advanced stages (e.g., end-stage renal disease, stage 4 CKM).

    “Conversely, in advanced stages (e.g., end-stage renal disease, stage 4 CKM), the association frequently becomes U-shaped, with low TyG-BMI paradoxically linked to excess mortality.”

    Reviewin advanced stages (e.g., end-stage renal disease, stage 4 CKM)

    Insulin resistance, metabolic phenotypes, and the obesity paradox: a triglyceride glucose-body mass index framework in partial kidney diseases

    Frontiers in endocrinology

Cardiovascular disease

upin humans6+17%OR 3.988

6 studies
  1. TyG-BMI is associated with cardiovascular disease in humans (Highest change class of TyG-BMI; initially CVD-free participants) (OR 3.988, 95% CI 3.419–4.650).

    “The highest change classes of all indices showed significantly increased CVD risk, with the strongest associations observed for TyG-BMI (OR: 3.988, 95% CI: 3.419-4.650)”

    HumansHighest change class of TyG-BMI; initially CVD-free participantsMedian follow-up of 66 monthsn = 19,315

    Association between changes in obesity- and lipid-related indices and the risk of cardiovascular disease: a prospective cohort study in Northwest China

    Frontiers in endocrinology

  2. TyG-BMI is linked with a higher risk of cardiovascular disease in humans (elevated TyG-BMI and hs-CRP levels) (aHR 1.215 (95% CI 1.085-1.362)).

    “presence of elevated TyG-BMI and hs-CRP levels was significantly associated with an increased risk of CVD, with an adjusted hazard ratio (aHR) of 1.215 (95% CI 1.085-1.362).”

    Humanselevated TyG-BMI and hs-CRP levelsn = 9,190

    Association of combined TyG-BMI and hs-CRP with incident cardiovascular disease in an aging Chinese population: A nationwide prospective cohort study

    Clinical nutrition ESPEN

  3. TyG-BMI is linked with a higher risk of cardiovascular disease in humans (HR 3.58 (95% CI 2.50-5.14)).

    “TyG-BMI was positively associated with CVD risk (HR = 3.58, 95% CI 2.50-5.14)”

    Humans

    Insulin resistance-related indices, sarcopenia, and cardiovascular risk in CKM stages 1-3: a prospective cohort study from CHARLS

    BMC endocrine disorders

  4. TyG-BMI is linked with a higher risk of cardiovascular disease in humans (Q4 vs Q1) (HR 1.74, 95% CI 1.51-2.01).

    “TyG-BMI, TyG-waist-to-height ratio (WHtR), and TyG-weight-adjusted-waist index (WWI) were 1.36 (95%CI: 1.19-1.57), 1.74 (95%CI: 1.51-2.01)”

    HumansQ4 vs Q19-year follow-upn = 6,158

    Association between triglyceride glucose index combined with obesity index and cardiovascular disease risk in middle-aged and old adults in China

    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

  5. TyG-BMI is linked with a higher risk of cardiovascular disease in humans (without diabetes, highest vs lowest tertile) (HR 1.92, 95% CI 1.19-3.10).

    “TyG-body mass index (BMI) (HR 1.92, 95% CI 1.19-3.10)”

    Humanswithout diabetes, highest vs lowest tertilen = 6,890

    Effectiveness of the triglyceride-glucose index and triglyceride-glucose-related indices in predicting cardiovascular disease in middle-aged and older adults: A prospective cohort study

    Journal of clinical lipidology

  6. TyG-BMI raises the risk of cardiovascular disease in humans (continuous analysis (per 1-SD increase)) (+17%).

    “per 1-SD increase, cardiovascular disease (CVD) risk increased by 17%, 20%, and 19% for TyG-BMI, TyG-WC, and TyG-WHtR, respectively (28 studies)”

    Reviewcontinuous analysis (per 1-SD increase)n = 28

    Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis

    Cardiovascular diabetology

More on Cardiovascular disease

Sarcopenia

upin humans5downin humans1OR 0.14–3.34

5 studies
  1. TyG-BMI predicts sarcopenia in humans (cross-sectional analysis in CHARLS, compared with other candidate composite biomarkers) (AUC 0.938).

    “Among the evaluated composite biomarkers, TyG-BMI showed the highest discriminative ability for sarcopenia (AUC = 0.938).”

    Humanscross-sectional analysis in CHARLS, compared with other candidate composite biomarkersn = 1,343

    Development and external validation of a composite biomarker-based machine learning model for sarcopenia risk stratification in patients with cardiovascular disease

    Frontiers in cardiovascular medicine

  2. TyG-BMI predicts sarcopenia in humans.

    “Additionally, TyG-BMI yielded the largest AUC among the seven indices.”

    Humansn = 5,329

    Correlation Between Various Insulin Resistance Indices and Sarcopenia: Evidence from CHARLS

    Research SquarePreprint

  3. TyG-BMI is linked with a lower risk of sarcopenia in humans (OR 0.14, 95% CI 0.10–0.19).

    “In fully adjusted models (Model 3), all seven IR surrogates were significantly associated with SA. Per standard-deviation increase, adjusted odds ratios (OR, 95% CI) were: TG/HDL 0.84 (0.74–0.95), TyG 0.65 (0.53–0.80), TyG-BMI 0.14 (0.10–0.19)”

    Humansn = 5,329

    Correlation Between Various Insulin Resistance Indices and Sarcopenia: Evidence from CHARLS

    Research SquarePreprint

  4. TyG-BMI is linked with a higher risk of sarcopenia in humans (OR 1.15, 95% CI 1.13-1.18).

    “TyG-BMI: OR (95% CI): 1.15 (1.13, 1.18)”

    Humansn = 4,804

    Associations between different triglyceride glucose index-related obesity indices and sarcopenia: a cross-sectional study

    Frontiers in endocrinology

  5. TyG-BMI predicts sarcopenia in humans (AUC 0.892 (95% CI: 0.860-0.924)).

    “Specifically, TyG-BMI showing the highest AUC of 0.892 (95% confidence interval: 0.860-0.924), indicating its strong predictive potential.”

    Humansn = 792

    Association of triglyceride-glucose index and its combinations with sarcopenia among community-dwelling older adults: based on the Chongqing Aging and Sarcopenia Evaluation (CHASE) cohort

    Frontiers in physiology

  6. TyG-BMI is linked with a higher risk of sarcopenia in humans (Q4 vs Q1) (OR 3.34, 95% CI: 1.92-5.80).

    “followed by TyG-BMI (Q4: 3.34; 95% CI: 1.92-5.80, P < 0.001)”

    HumansQ4 vs Q1n = 7,161

    Association of triglyceride glucose-related obesity indices with sarcopenia among U.S. adults: a cross-sectional study from the National Health and Nutrition Examination Survey

    Scientific reports

More on Sarcopenia

Cardiometabolic multimorbidity

upin humans4HR 1.28–3.4

4 studies
  1. TyG-BMI is associated with cardiometabolic multimorbidity in humans (per 1-SD increase in baseline TyG-BMI) (HR 1.28, 95% CI 1.17–1.40).

    “Baseline and cumulative average TyG-BMI were associated with CMM (HR per 1-SD increase 1.28, 95% CI 1.17–1.40; and 1.25, 95% CI 1.14–1.37, respectively)”

    Humansper 1-SD increase in baseline TyG-BMI2015–2020n = 4,597

    Differential associations of baseline, dynamic change, and cumulative average TyG-BMI with incident cardiometabolic multimorbidity: a longitudinal landmark analysis of CHARLS

    Scientific reports

  2. TyG-BMI is linked with a higher risk of cardiometabolic multimorbidity in humans (elevated versus reduced eGDR-BMI, in adults with hypertension and sarcopenia) (HR > 1.5).

    “Kaplan–Meier analysis demonstrated that elevated TyG–BMI conferred a stronger association with cumulative CMM incidence than reduced eGDR–BMI (HR > 1.5, p < 0.01).”

    Humanselevated versus reduced eGDR-BMI, in adults with hypertension and sarcopenia

    Correlation of BMI-related insulin resistance and cardiometabolic multimorbidity risk in the hypertension with sarcopenia adults

    Critical Public Health

  3. TyG-BMI is linked with a higher risk of cardiometabolic multimorbidity in humans (comparing highest vs. lowest quartile) (HR = 2.146).

    “closely followed by TyG-BMI (HR = 2.146)”

    Humanscomparing highest vs. lowest quartile4.3 yearsn = 304,586

    Associations of TyG-Derived Indices with Cardiometabolic Multimorbidity Risk in Community-Dwelling Older Adults: A Longitudinal Analysis Based on the GOLD-Health Cohort

    Nutrients

  4. TyG-BMI is linked with a higher risk of cardiometabolic multimorbidity in humans (high index with low eGDR versus low index with high eGDR) (HR 3.40, 95% CI 2.30-5.02).

    “TyG-BMI (HR 3.40, 95% CI 2.30-5.02)”

    Humanshigh index with low eGDR versus low index with high eGDR

    Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study

    Cardiovascular diabetology

More on Cardiometabolic multimorbidity

Osteoporosis

downin humans2upin humans1OR 0.985

3 studies
  1. TyG-BMI is linked with a lower risk of osteoporosis in patients with type 2 diabetes mellitus (OR 0.985, 95% CI 0.978-0.992).

    “each one-unit increase in TyG-BMI was associated with a 1.5% lower odds of osteoporosis (OR = 0.985, 95% CI: 0.978-0.992)”

    Humansin patients with type 2 diabetes mellitusn = 892

    Linear Inverse Association Between Triglyceride Glucose-Body Mass Index and Osteoporosis in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

    Diabetes, metabolic syndrome and obesity : targets and therapy

  2. TyG-BMI is linked with a lower risk of osteoporosis in humans (adjusted Cox regression) (HR 0.991, 95% CI 0.984-0.999).

    “0.991 (95%CI 0.984-0.999) and 0.929 (95%CI 0.892-0.968), respectively”

    Humansadjusted Cox regression2015 until 2022malesn = 1,622

    Role of TyG, TyG-BMI and METS-IR in osteoporosis risk among older men: a retrospective cohort study

    Asia Pacific journal of clinical nutrition

  3. TyG-BMI predicts osteoporosis in patients with T2DM.

    “Machine learning analysis identified TyG-BMI as the strongest predictor for type 2 diabetic osteoporosis in middle-aged and elderly patients.”

    Humansin patients with T2DM

    The correlation between TyG-BMI and the risk of osteoporosis in middle-aged and elderly patients with type 2 diabetes mellitus

    Frontiers in nutrition

  4. TyG-BMI is linked with a higher risk of osteoporosis in patients with T2DM (95%CI 1.031-1.054, P < 0.01).

    “Notably, TyG-BMI also emerged as an independent risk factor for OP (95%CI 1.031-1.054, P < 0.01).”

    Humansin patients with T2DM

    The correlation between TyG-BMI and the risk of osteoporosis in middle-aged and elderly patients with type 2 diabetes mellitus

    Frontiers in nutrition

More on Osteoporosis

Stroke

upin humans3OR 1.186–1.62

3 studies
  1. TyG-BMI is linked with a higher risk of stroke in humans (abnormal glucose metabolism) (adjusted OR 1.186, 95% CI 1.022-1.376 per SD increase).

    “1.186 (1.022-1.376), 1.222 (1.069-1.396), and 1.193 (1.050-1.355), respectively.”

    Humansabnormal glucose metabolism

    Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study

    Cardiovascular diabetology

  2. TyG-BMI is linked with a higher risk of stroke in humans (non-hypertension) (HR 1.47 (1.05-2.05)).

    “Compared to patients with lower TyG-BMI (TyG-BMI < 199.74) levels and non-hypertension, those with elevated TyG-BMI levels and non-hypertension had an adjusted hazard ratio (HR) and 95% confidence intervals (95%CI) were 1.47 (1.05-2.05).”

    Humansnon-hypertension7-year follow-upn = 6,922

    Combined effect of triglyceride glucose-body mass index and hypertension on new-onset stroke: evidence from the China health and retirement longitudinal study

    Frontiers in public health

  3. TyG-BMI is linked with a higher risk of stroke in humans (middle-aged and older Chinese adults) (OR 1.62, 95% CI 1.11-2.32).

    “the OR for a high TyG-BMI with a slow rising trend was 1.62 (95% CI 1.11-2.32)”

    Humansmiddle-aged and older Chinese adults3 yearsn = 4,583

    Changes in the triglyceride glucose-body mass index estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study

    Cardiovascular diabetology

More on Stroke

Metabolic dysfunction-associated steatotic liver disease

upin humans2

2 studies
  1. TyG-BMI predicts metabolic dysfunction-associated steatotic liver disease in humans (Chinese health checkup cohort).

    “TyG‐BMI, TyG‐WC, TyG‐WHtR, and METs‐IR showed superior discriminative ability (AUC: 0.864–0.929) and outperformed TyG and TyG‐WHR.”

    HumansChinese health checkup cohortn = 2,623

    Comparative performance of six insulin resistance surrogate indices for identifying metabolic dysfunction–associated steatotic liver disease in a Chinese health checkup cohort

    Frontiers in endocrinology

  2. TyG-BMI predicts metabolic dysfunction-associated steatotic liver disease in humans (AUC 0.758).

    “TyG-BMI demonstrated numerically higher AUC values than the HSI (Men: TyG-BMI 0.758 vs. HSI 0.747; Women: TyG-BMI 0.759 vs. HSI 0.756), with overlapping confidence intervals.”

    Humansmedian six-year follow-upmalesn = 2,757

    Triglyceride glucose-body mass index as a practical screening tool for metabolic dysfunction-associated steatotic liver disease in older adults: A community-based cohort study

    Asia Pacific journal of clinical nutrition

  3. TyG-BMI is linked with a higher risk of metabolic dysfunction-associated steatotic liver disease in humans (highest versus lowest quartile) (aHR 6.42 (95% CI: 5.33-7.73)).

    “triglyceride glucose-body mass index (TyG-BMI) demon-strated the highest risk, with an adjusted hazard ratio of 6.42 (95% CI: 5.33-7.73) for the highest versus lowest quartile.”

    Humanshighest versus lowest quartilemedian six-year follow-upn = 2,757

    Triglyceride glucose-body mass index as a practical screening tool for metabolic dysfunction-associated steatotic liver disease in older adults: A community-based cohort study

    Asia Pacific journal of clinical nutrition

More on Metabolic dysfunction-associated steatotic liver disease

Diabetes mellitus

upin humans2OR 1.14

2 studies
  1. TyG-BMI is linked with a higher risk of diabetes mellitus in humans (liver disease) (OR = 1.14, 95%CI = 1.06-1.22).

    “the triglyceride-glucose-body mass index (TyG-BMI) (OR = 1.14, 95%CI = 1.06-1.22) promoted DM in male patients”

    Humansliver diseasemales

    Optimal obesity and lipid-related predictors of diabetes mellitus in middle-aged and elderly patients with liver disease in China: a CHARLS cross-sectional study

    Diabetology international

  2. TyG-BMI predicts diabetes mellitus in humans (cutoff 213.2966) (AUC 0.7741, sensitivity 72.51%, specificity 69.54%).

    “the best TyG-BMI cutoff value for predicting new-onset diabetes was 213.2966 (area under the curve 0.7741, sensitivity 72.51%, specificity 69.54%)”

    Humanscutoff 213.29663.1 yearsn = 116,661

    Triglyceride Glucose-Body Mass Index and The Risk of Diabetes: A General Population-Based Cohort Study

    Research SquarePreprint

  3. TyG-BMI is linked with a higher risk of diabetes mellitus in humans (multivariate Cox regression) (HR 1.50 per SD increase, 95%CI: 1.40 to 1.60).

    “TyG-BMI was an independent predictor of new-onset diabetes (HR 1.50 per SD increase, 95%CI: 1.40 to 1.60, P-trend<0.00001)”

    Humansmultivariate Cox regression3.1 yearsn = 116,661

    Triglyceride Glucose-Body Mass Index and The Risk of Diabetes: A General Population-Based Cohort Study

    Research SquarePreprint

More on Diabetes mellitus

Frailty

upin humans2OR 1.83–2.16

2 studies
  1. TyG-BMI is associated with frailty in humans (fourth quartile vs first quartile of baseline TyG-BMI) (OR 1.83, 95% CI 1.61-2.09).

    “fourth (OR = 1.83, 95% CI: 1.61-2.09) quartiles of baseline TyG-BMI”

    Humansfourth quartile vs first quartile of baseline TyG-BMIn = 9,135

    Relationship between changes in the triglyceride glucose-body mass index and frail development trajectory and incidence in middle-aged and elderly individuals: a national cohort study

    Cardiovascular diabetology

  2. TyG-BMI is linked with a higher risk of frailty in humans (fourth quartile vs first quartile of baseline TyG-BMI) (HR 1.42, 95% CI 1.28-1.58).

    “Higher frail risk was noted in those in the fourth quartile of baseline TyG-BMI (HR = 1.42, 95% CI: 1.28-1.58)”

    Humansfourth quartile vs first quartile of baseline TyG-BMIn = 9,135

    Relationship between changes in the triglyceride glucose-body mass index and frail development trajectory and incidence in middle-aged and elderly individuals: a national cohort study

    Cardiovascular diabetology

  3. TyG-BMI is linked with a higher risk of frailty in humans (fully adjusted model, Q4 vs. Q1) (OR 2.16, 95% CI 1.76–2.64).

    “TyG- BMI Q4 vs. Q1, OR = 2.16, 95% CI: 1.76, 2.64, P < 0.001”

    Humansfully adjusted model, Q4 vs. Q1n = 7,965

    Association of the triglyceride-glucose index and its related parameters with frailty

    Lipids in health and disease

Venous thromboembolism

upin humans2HR 1.7–1.86

2 studies
  1. TyG-BMI is associated with venous thromboembolism in humans (Highest quartile of TyG-BMI) (HR 1.86, 95% CI 1.76–1.98).

    “Participants in the highest quartiles of TyG, TyG-BMI, TyG-WC, TyG-WHtR, TyG-BRI, TyG-ABSI, TyG-WWI, and TyG-VAI exhibited elevated risk of VTE”

    HumansHighest quartile of TyG-BMI

    Associations of Triglyceride Glucose Index-related Obesity Indices, Genetic Susceptibility, and the Risk of Venous Thromboembolism: Insights from a Prospective Cohort Study

    Thrombosis and haemostasis

  2. TyG-BMI is linked with a higher risk of venous thromboembolism in humans after adjusting for potential confounders (HR 1.70, 95% CI 1.63–1.76).

    “as well as with every 100 unit increase in TyG-BMI (HR: 1.70, 95% CI: 1.63–1.76, P < 0.001, E value = 2.79)”

    Humansafter adjusting for potential confoundersevery 100 unit increasen = 502,131

    Association of triglyceride-glucose related indices with the incidence of venous thromboembolism: a nationwide prospective cohort study based on the UK Biobank

    BMC cardiovascular disorders

More on Venous thromboembolism

All 56

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    One human study links higher TyG-BMI to type 2 diabetes; another links it to hypertension–diabetes comorbidity. A human study reports insulin resistance prediction in adults without diabetes, but another reports no effect on hypertension in people with type 2 diabetes or prediabetes.

  2. Summary written from the findings.

Latest

Dec 2025: 10Jan 2026: 21Feb 2026: 22Mar 2026: 21Apr 2026: 4May 2026: 3Jun 2026: 7Jul 2026: 11Aug 2026: 19Sep 2026: 20Oct 2026: 29Nov 2026: 10177 papers in 12 months

See all 264 papers on TyG-BMI